Literature DB >> 11872053

Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis.

A Buter1, C W Imrie, C R Carter, S Evans, C J McKay.   

Abstract

BACKGROUND: All patients with organ dysfunction are currently classified as having severe acute pancreatitis. The aim of this study was to characterize the systemic inflammatory response syndrome (SIRS) and early organ dysfunction in patients with acute pancreatitis and the relationship with overall mortality.
METHODS: Patients with predicted severe acute pancreatitis of less than 48 h duration had daily organ dysfunction scores and SIRS criteria calculated. These features were then correlated with outcome.
RESULTS: Of 121 patients, 68 (56 per cent) did not develop organ dysfunction; only two of these patients died (mortality rate 3 per cent). Fifty-three (44 per cent) had early organ dysfunction, of whom 11 died (21 per cent). Organ dysfunction and persistent SIRS were both associated with an increased mortality rate, but on multivariate analysis only deteriorating organ dysfunction was an independent determinant of survival.
CONCLUSION: Early organ dysfunction in acute pancreatitis usually resolves and in itself has no significant influence on mortality. In contrast, worsening organ dysfunction was associated with death in more than half of the patients (11 of 20); it is this group of patients who should be classified as having severe acute pancreatitis.

Entities:  

Mesh:

Year:  2002        PMID: 11872053     DOI: 10.1046/j.0007-1323.2001.02025.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  130 in total

1.  Oxymatrine ameliorates L-arginine-induced acute pancreatitis in rats.

Authors:  Zhiqiang Zhang; Yanqing Wang; Ming Dong; Jianchun Cui; Daqing Rong; Qi Dong
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

2.  Walled-off pancreatic necrosis: wishing our pancreatitis nomenclature was correct.

Authors:  Arkadiusz Peter Wysocki
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

Review 3.  Multidetector CT in emergency radiology: acute and generalized non-traumatic abdominal pain.

Authors:  Pasquale Paolantonio; Marco Rengo; Riccardo Ferrari; Andrea Laghi
Journal:  Br J Radiol       Date:  2016-01-22       Impact factor: 3.039

Review 4.  Management of acute pancreatitis: from surgery to interventional intensive care.

Authors:  J Werner; S Feuerbach; W Uhl; M W Büchler
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  UK guidelines for the management of acute pancreatitis.

Authors: 
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

6.  Case-matched comparison of the retroperitoneal approach with laparotomy for necrotizing pancreatitis.

Authors:  Hjalmar C van Santvoort; Marc G Besselink; Thomas L Bollen; Erik Buskens; Bert van Ramshorst; Hein G Gooszen
Journal:  World J Surg       Date:  2007-06-16       Impact factor: 3.352

7.  Relative adrenal insufficiency in patients with severe acute pancreatitis.

Authors:  Jan J De Waele; Eric A J Hoste; Didier Baert; Koen Hendrickx; Dirk Rijckaert; Patrick Thibo; Philippe Van Biervliet; Stijn I Blot; Francis Colardyn
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

8.  Role of toll-like receptor 4 in the pathophysiology of severe acute pancreatitis in mice.

Authors:  Hidehiro Sawa; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Takahiro Nakajima; Yoshikazu Kuroda
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

9.  Tumor necrosis factor alpha antibody prevents brain damage of rats with acute necrotizing pancreatitis.

Authors:  Yan-Ling Yang; Ji-Peng Li; Kai-Zong Li; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

Review 10.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.